ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022

Rhea-AI Summary

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will release its Q1 2022 financial results on May 10, 2022. A conference call will follow at 8:30 a.m. ET to discuss these results. The call can be accessed via a toll-free number and a webcast available on their website. ANI focuses on developing, manufacturing, and marketing high-quality branded and generic pharmaceuticals, aiming for sustainable growth through its Purified Cortrophin™ Gel franchise and enhanced generics business.

Positive

• Focus on developing high-quality branded and generic pharmaceuticals.
• Plans for sustainable growth through the Purified Cortrophin™ Gel franchise.

Negative

• None.

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2022 financial results on Tuesday, May 10, 2022.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date: Tuesday, May 10, 2022
Time: 8:30 a.m. ET
Toll free (U.S.): 866-342-8591
Webcast (live and replay): www.anipharmaceuticals.com, under the “Investors” section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-753-4606 and entering access code 5146584.

About ANI
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin™ Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220419005351/en/

Investor Relations Contact:

Lisa M. Wilson, In-Site Communications, Inc.

212-452-2793

lwilson@insitecony.com

Media Contact:

Angela Salerno-Robin

dna Communications

212-445-8219

ASalerno-Robin@dna-comms.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals release its Q1 2022 financial results?

ANI Pharmaceuticals will release its Q1 2022 financial results on May 10, 2022.

What time is the conference call for ANI Pharmaceuticals' Q1 results?

The conference call will take place at 8:30 a.m. ET on May 10, 2022.

How can I access the conference call for ANI Pharmaceuticals?

The conference call can be accessed via a toll-free number or through a webcast on the ANI Pharmaceuticals website.

What key products does ANI Pharmaceuticals focus on?

ANI Pharmaceuticals develops and markets high-quality branded and generic prescription pharmaceutical products, including the Purified Cortrophin™ Gel.